Bioxytran (BIXT) Cash & Equivalents (2011 - 2026)
Bioxytran (BIXT) posted Cash & Equivalents of $177,384 for Q2 2026, compared with $3,144 a year earlier and down 61.7% from the prior quarter.
Powered by 
Analysis
Bioxytran (BIXT) Cash & Equivalents (2011 - 2026) Analysis & Trends
At the end of FY2025, Bioxytran's Cash & Equivalents came in at $509,914.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of 65.0% (FY2020 to FY2025).
- In prior years, Bioxytran's Cash & Equivalents was $5,154 in FY2024 (-80.2%), $26,086 in FY2023 (-91.2%), $295,401 in FY2022 (+308.2%) and $72,358 in FY2021 (+73.6%).
- Quarterly Cash & Equivalents has run from a low of $3,144 in Q2 2025 to a high of $739,584 in Q1 2022 over five years.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q1 2022, with growth of 707.1%; the weakest was Q1 2024, with a decline of 93.5%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $463,047 (Q1 2026), $509,914 (Q4 2025) and $14,499 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Bioxytran | 2.29 Mn | 1.13 Mn | - | 177,384.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 177,384.00 |
| Mar 31, 2026 | 463,047.00 |
| Dec 31, 2025 | 509,914.00 |
| Sep 30, 2025 | 14,499.00 |
| Jun 30, 2025 | 3,144.00 |
| Mar 31, 2025 | 4,348.00 |
| Dec 31, 2024 | 5,154.00 |
| Sep 30, 2024 | 34,672.00 |
| Jun 30, 2024 | 13,522.00 |
| Mar 31, 2024 | 10,024.00 |
| Dec 31, 2023 | 26,086.00 |
| Sep 30, 2023 | 80,273.00 |
| Jun 30, 2023 | 45,181.00 |
| Mar 31, 2023 | 153,801.00 |
| Dec 31, 2022 | 295,401.00 |
| Sep 30, 2022 | 374,190.00 |
| Jun 30, 2022 | 500,677.00 |
| Mar 31, 2022 | 739,584.00 |
| Dec 31, 2021 | 72,358.00 |
| Sep 30, 2021 | 243,994.00 |
API Access
Bioxytran Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BIXT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "BIXT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BIXT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();